This page is part of the FHIR Specification (v1.2.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
This is the narrative for the resource. See also the XML or JSON format.
Capecitabine (Recurrent/Metastatic)
Course:
Name: Capecitabine
Agent Protocols Options:
Capecitabine 1000-1250 mg/m^2 PO twice daily D1-14
Offset: None
Cycle length: Q21D
Other examples that reference this example:
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.